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KAMLET LABORATORIES AND
CLINITEST: IDEA TO PRODUCT
Dean F. Martin and Brodie A. Reiger
Institute for Environmental Studies, Department of Chemistry,
University of South Florida, Tampa, FL, USA

This article examines the process of development of Clinitest pills that could be used in clinicsor physicians' offices for rapid, convenient analysis of glucose and other components of clinical interest. It was
invented by Dr. Jonas Kamler. We were able to follow the process because his papers are accessible

(as The Kamlet Laboratories Collection) at the University of South Florida Library. The accessibilityof
these papers gives an opportunity to see steps in the development of a successful product from conception
to patent and commercialization. Kamlet, a consulting chemist, took the invention to Miles Laboratories
of Elkhart, Indiana, in the early I 940s. Ultimately, it was replaced by a Miles invention, Clinistix,which
had the same purpose. While Dr. Kamlet earned money for his two-person laboratory, contemporary
accounts give credit to the Director of Miles Laboratories, Walter Ames Compton, M.D., for the invention of Clinitest, Correspondence between Kamlet Laboratories and Miles Laboratories (1940-1945)was
reviewed, with no written evidence of hurt feelings or acrimony discovered.
Key words: Clinitest; Clinistix; Miles Laboratories;

Recognition; Invention

INTRODUCTION
How does an inventor receive credit for his or
her invention? Sometimes a name is attached to a
process invented, such as the Hall Process or the
Heroult process for the electrochemical production
of aluminum (16). There is a plethora of organic
reactions named for their inventors. But too many
times, credit is not forthcoming, especially for a
hired consultant. The authors had the opportunity
to examine a particular situation of the development of an idea from patent to product by examining the Kamlet papers available at the USF Library.
The files of Kamlet Laboratories (vide infra) were
donated to USF in 2006 (15,18). A website was set
up so that chemists and other interested persons
may view the general contents of the Karnlet papers
(13). The first manuscript in the series described
the origin of the collection (14). A second manuscript (15) considered details of the early years of

operation using information found in the Kamlet
Laboratories Collection at USF (18). This article
is concerned with the development of an idea by
Dr. Jonas Kamlet: pills that would allow rapid,
accurate tests of important clinical constituents to
be made in physicians' offices.
Our study revealed a noticeable absence of credit
given to Dr. Kamlet, inventor of a product called
Clinitest, marketed for a number of years by Miles
Laboratories, then of Elkhart, Indiana. Sold as pills,
Clinitest was designed to test biological fluids for
glucose and other components of interest in the
treatment of diabetes. In 2010, an estimated 25.8
million children and adults (8.3%) of the US population had diabetes. Some 18.8 million of that number
were diagnosed (2). Today, the preferred analysis
for glucose testing is the blood glucose meter, but
in the past, urine glucose concentrations were tested
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by chemical means, then by pills, then by strip tests
(vide infra) (2,3).
Few persons are aware of the background of the test
strips Clinistix or appreciate that perhaps some of the
credit should go to the person who was responsible for
obtaining the first patent for what became Clinitest,
the forerunner of these strips at Miles Laboratories
(3,4). We believe that some credit should go to the
founder of Kamlet Laboratories (New York, NY),
Dr. Jonas Kamlet, a man who developed a unique system of chemical entrepreneurship. He was assisted in
the activities of the Kamlet Laboratories by his wife,
the late Edna Yadven Kamlet Rogers, a resident of
Sarasota, Florida (14).

the development of products for comprehensive health
care. Though many of the developments occurred in
the late 1960s and early 1970s, One-a-Day vitamins
had been developed much earlier and were first marketed in 1943 (4,17). Jonas Kamlet also deserves partial credit for this product (12).
However, the company may have become too
attractive and, in October 1977, was subjected to a
takeover bid by Bayer AG (West Germany). The firm
was converted to the North American division of
Bayer AG and later became defunct in 1995 as Bayer
removed the Miles name from all products and facilities. The US headquarters was moved from Elkhart
to Pittsburgh (17).

BACKGROUND OF MILES LABORATORIES

BACKGROUND OF KAMLET
LABORATORIES

This section considers some salient features of Miles
Laboratories' -widely
famous for Alka-Seltzerinteresting and varied history (4,5,17). Starting as
Dr. Miles' Medical Company (established by Dr.
Franklin Miles of Elkhart, Indiana) in 1885, the founder
was soon joined by two colleagues-George Compton
and Albert Beardsley-and the trio became responsible
for Miles Laboratories. Descendants of the trio, including Dr. Arthur Compton, would later be executives
within the firm (4).
The company was profitable within 5 years, in major
part because of the sales of a sedative, "Dr. Miles'
Restorative Nervine" (4). Subsequently, Alka-Seltzer
would be a major seller, a product that was suggested
by Andrew "Hub" Beardsley, nephew of a trio member
and later first Chairman of the Board (4,5,17). Having
noted that reporters of a local newspaper seemed to
resist colds by taking a mixture of aspirin and sodium
bicarbonate, he encouraged a different emphasis on
products. After years of experimentation, Alka-Seltzer
became available in 1931 (4,17).
The timing was excellent for this product, coming just before the repeal of prohibition (4,17). AlkaSeltzer was designed to alleviate headaches and upset
stomachs, "as the incidence of hangovers increased,
so did the consumption of Alka-Seltzer" (17). At last
report, it was available in more than 100 nations with
annual sales of $90 million (17).
The firm decided to diversify into a wider range
of products under the leadership of Dr. Walter Ames
Compton, company president from 1964 to 1973 and
later Chairman of the Board. Diversification included

The background of Kamlet Laboratories has
been described elsewhere (14,15). Briefly, Kamlet
Laboratories was founded in 1940. Laboratory personnel consisted of Jonas Kamlet and his wife, Edna
Yadven Kamlet (14,15). They specialized in consulting or in developing inventions and selling the
patent rights to interested companies. Though the
laboratory had some facilities for doing laboratory
experiments, the Kamlets also arranged subcontracted work to be done by others. Outside work,
however, was carefully divided by Edna Kamlet, so
that only the Kamlets knew how the components
would fit into a final product (14).
HOW IT STARTED
Jonas Kamlet was associated with Miles Laboratories in a number of ways according to the correspondence (10-12). How this association developed
requires a bit of background. Ultimately, 10 patents
that Dr. Kamlet developed were assigned to Miles
Laboratories. He developed ideas for diagnostic
compositions and methods of analyses of blood and
urine for specific components of interest in clinical chemistry that led to patents assigned to Miles
Laboratories (Table 1). The purpose was to provide
a rapid, simple, and convenient method for performing tests with a high degree of accuracy and specificity, one that can readily be used by the average
physician without laboratory equipment or specialized analytical training (7,8).
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'Iable.L Summary of Patents Awarded to Jonas Kamlet and Assigned to Miles Laboratories*
Date

Patent Number

4128/1942

2,280,918

5/19/1942

2,283,262

Preparation of ortho-hydroxycinnamic
acid (substance is "valuable as an intermediate in
manufacture of coumarin, which is.extensively used as a flavoring material")
Diagnostic composition and method (detection/quantitative estimation of acetone and
acetoacetic acid in body fluids)

7/21/1942

2,290,436

Diagnostic composition and method (qualitative detection/semi-quantitative

Title

estimation of

bloodin bodyfluids)
2/09/1943
3/23/1943

CA 410,533**
2,314,831

5/25/1943

2,320,282

4/11/1944
6/19/1945
9/03/1946
3/25/1947

2,346,261
2,378,559
2,406,774
2,418,033

Reagent mixture for determination of reducing sugar (e.g., glucose)
Preparation of n-tartaric acid by fermentation (economical method using cheap, readily
available raw materials)
Diagnostic compositions for amino-arylsulfcnamides
(simple test for estimate of "sulfa"
compounds)
Titration reaction vessel (used in a diagnostic method)
Synthetic elastomers (new rubber line synthetic polymers)
Synthesis of riboflavin and intermediates Therefore (new synthesis of Vitamin B~)
Diagnostic compositions (detection/quantitative,
estimation of glucose, etc. in body fluids)

*us patent search: http://www.pat2pdf.org/
**Canadian patent, Canadian Intellectual Property Office: cipo.ic.gc.ca

Dr. Kamlet would use a method (e.g., BenedicI's
reagenI for glucose); develop it for clinical use; and
convert the necessary reagents into, for example,
five-grain tablets, and the tablets would then be
agitated to produce carbon dioxide when dissolved
in water (7,8). One patent was concerned with the
analysis of acetone and acetoacetic acid (Table I)
(7). Another was concerned with the analysis of
"occult blood" in body fluids and feces (8). A third
was concerned with the analysis of sulfa drugs in
body fluids, using 2.5-grain tablets. The analyses
provide a good estimate of concentrations of antibiotics at a time when proper doses had not been
established (cf. Table I, Patent 2,320,282). A fourth
was concerned with the estimation of reducing carbohydrates such as glucose, levulose, and arabinose
in body fluids (urine, cerebrospinal fluid, milk). The
patent titled "Diagnostic Compositions" was a conlinuation in part of copending applications.
Clearly, Jonas Kamlet had developed an idea for
a tablet that could be used in tests for diabetes, and
these were covered in patents assigned to Miles
Laboratories (7-9). He needed a convenient method
for agitating the solution, and his wife suggested
contacting Miles Laboratories because they manufactured Alka-Seltzer and would know how to agitate something in solution using a pill (14). Further
development of the story from the Kamlet point of
view has been described elsewhere (14,15).

Dr, Kamlet had a sound appreciation of how the
mixture worked (10). In a December 1943 letter
(12), he noted why "the sodium hydroxide and the
citric acid go so well together in our Clinitest tablets until (sic) the tablet is wetted. Then they interact
like all get out" (10). He cited an old Aristotelian
dictum that he wrote still held good: Corpore non
agunt nisi solute or "bodies do not interact unless
they are dissolved" (12).

KAMLET AND PUBLIC RELATIONS
Jonas Kamlet realized that there was a need for
publicity for the Clinitest products, and his ideas
are outlined in a letter written to Dr. R. L. Conklin
(11), a popular Elkhart physician who helped run
the Miles medical facility on a part time basis during World War II:
One of the next steps that I believe we ought to
take in the introduction of our Clinitest series to the
physicians and clinical pathologists of this country,

is to publish a paper in one of thejournals (e.g., the
Journal of Laboratory and Clinical Medicine is my

choice) (10).
It is hard to disagree with the wisdom of this idea,
but it is interesting to read further in the letter. He noted
on May 5, 1942, that he "forwarded to Dr. Compton a

a
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16-page letter containing an extensive bibliography to
serve as the basis around which we could construct the
first Clinitest paper." He also suggested that, at their
next meeting, they "should discuss the advisability of
publishing this paper in the near future as well as lay
down a policy for future publications" (10).
Jonas Kamlet had another idea, which he added at
the end of the first paragraph: "The author of the introductory paper must be what appears to be a disinterested outsider. I suggest that Dr. Casper of the Herman
Keefer Hospital in Detroit be requested to 'author' the
first Clinitest paper which we can ghost-write for him"
(10). Thus far, we have been unable to fmd the ghostwritten paper, either in manuscript or published form.
Dr. Kamlet was an enthusiastic proponent of the
Clinitest kits. In 1943, he wrote to Dr. Raymond L.
Conklin at Miles about a visit to the International
Paper Company at Glens Falls, New York. He specifically noted that there were two problems that he
suggested could be solved using the Clinitest kit. He
wrote, "During a second trip, I brought along one
of these [kits] and demonstrated its use. Dr. Taylor
and his staff were very interested and wanted to
know where they could buy this kit" (11). Kamlet
was unable to find a pharmacy in Glens Falls that
stocked the Clinitest kit, so he suggested sending a
half dozen complimentary kits to Dr. Taylor (II).
THE IMPROVEMENTS
Bohning (3) wrote an article based on the Chemical
Heritage Foundation's Oral History Program. He
noted that just before Dr. Alfred Free (codeveloper of
Clinistix) arrived, "Miles [Laboratories] had developed Clinitest, a tablet for monitoring the glucose in
urine for diabetic patients. The tablet, based on the
relatively simple chemistry of Benedict's reagent
(CuSO" NaOH, and tartaric acid) contained cupric
sulfate, citric acid, sodium hydroxide, and because
it came from Miles-a little bit of carbonate to make
it fizz." Dr. Alfred Free's research group improved
the Clinitest process and increased the sensitivity so
that amounts of glucose up to 5% could be detected,
rather than stopping at 2%.
One of the problems with Clinitest tablets, according to Helen Free in an oral presentation (6), was
that the bottle had a skull and crossbones on it (4).
Subsequently, Dr. Alfred Free "realized that paper

could be impregnated with the reagent and a drop
of urine added. Finally, even the dropper was eliminated by cutting the paper into test strips so that the
strips could simply be dipped into the urine. The
concept of the Clinistix was born" (4).
The system had a number of assets--eonvenience,
safety, sensitivity, and an impressive range of analytes,
including density (6). Clinistix had a curious response
by some users. Bohning noted that the College of
American Pathologists had approved Clinitest as
the acceptable method for measuring urine reducing sugars (3). Clinistix was also accepted but with a
caveat that the test would need to be confirmed with
Clinitest, presumably a less sensitive test.
Credit to Dr. Walter Compton
Helen Free, codeveloper with her husband Dr. Al
Free, of Clinistix was interviewed in 2011 (1). The
resulting article said, "In the 1940s the company
[Miles Laboratories] had already introduced a test
called Clinitest, which was developed by Walter
Ames Compton, who would later become president
and chairman of the board at Miles" (I). The comparison of composition (Kamlet vs. Compton) is summarized in Table 2.
Jonas Kamlet did, in fact, receive some written
credit for his contribution. Cray (4) wrote that when
Compton "became head of research and development
at Miles, he became concerned as to whether something couldn't be done about making laboratory tests
more convenient. He enlisted the skills of a consulting
chemist, Jonas Kamlet, and Maurice Treneer, the inhouse expert on effervescence" (4). Clinistix tablets
still sold well more than 40 years after their introduction in 1941. In addition, the Kamlet papers indicate
involvement with other effervescence products (4).
In crediting Compton (1), was the Free research
group's contribution neglected? No, but neither does
the name Jonas Kamlet appear in either article.

CONCLUDING

REMARKS

Dr. Jonas Kamlet was a bright capable inventor
and chemist, who was also a shrewd businessman,
as evidenced by an analysis of the earnings of the
Kamlet Laboratories during the first 15 years (15).
It seems that the good living and the success of the

a
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Table 2. Letters to Dr. Raymond L. Conklin of Miles Laboratories in

1943

Subject

Dates

Dicoumarin anticoagulant
Exploitation of Patent 2,314,831 (manufacture of tartaric acid)
by u.s. Industrial Alcohol Corp (possibly on a license basis)

Cation-absorbing resin to remove iron from molasses in citric acid fermentations
Malazone tablets (60 grain effervescent) for mouthwash, antiseptic, general germicide
p- Thiocyanoaniline, agent for possible sulfanilamide-like activity;
Alternate synthesis of citric acid in face of wartime restrictions
Palatable effervescent colloidal aluminum hydroxide tablet, Alumi- Yess
Samples of proposed product, Alumi- Yess Hemibaslc calcium phosphate as a citric acid substitute
Nose-drop composition (samples)
Possible licensing arrangement with a Brazilian firm "for our tartaric acid process"
pH Clinitest tablets
Halazone tablets
Nasal vasoconstrictor preparation
(new sample prepared and sent)
Nasal vasoconstrictor - available trade names
Citric acid source (3 kg of waste tobacco stems); source of 3.8% mixture of citric and malic acids
Intention to file a patent on "our nasal vasoconstrictor preparation containing 2-aminoheptane-o-gluconate"
Comments of patent application for nasal vasoconstrictor (in response to patent examiner)
Multivitamin tablets
Vitamins A&D and the B complex. Technique for preparation; composition

firm were based on his success as an entrepreneur
and consultant, rather than an author of manuscripts
in refereed journals. In one sense, he could be
regarded as what some attorneys call a "hired gun."
He was financially compensated for what he produced, rather than for what he wrote for refereed
journals as would be true for a faculty member in a
major college or university today. As noted earlier,
some inventors are memorialized by having their
names attached to their invention. Paul L. T. Heroult
and Charles Martin Hall had their names attached
to the same invention but in different parts of the
world: Hall in the US and Heroult in the rest of the
world (16). The Colt pistol is another example, as
is the (Rudolph) Diesel engine, the (John) Deere
plow, the (Karl) Benz motor vehicle, and the (Cyrus)
McCormick harvester, among others.
Dr. Kamlet was not overlooked at the time (4). The
available correspondence with Miles Laboratories
available at USF (13) covers the period November 21,
1940 through April 19, 1945 (13). He seemed to
be on great terms with his correspondents (chiefly
Dr. Raymond Conklin) and typically closed his
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April 8
April 19
April 22
April 25
May4
April 24
May4
May8
June to
June 21
July7, 15
July30
August?
August 10
August 18
September 13
September 15
September 15
September 20
September 22
December 27
December 29
December 29

letters saying. "With kindest regards" (10-12). His
correspondence with representatives of Miles Laboratories reveals a helpful person, full of ideas (10-12).
This is amply indicated in Table 2.
We have seen no written concern over a lack of personal publicity for his efforts. His wife (the late Mrs.
Edna Yadveh Kamlet Rogers) may have focused on
a topic more important than fame-money. She said
of a certain patent assigned to Miles Laboratories that
they (the Kamlets) earned $5 million in 5 years; they
had expected to earn $17 million (14).
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